相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Standard Versus Prolonged Doripenem Infusion for Treatment of Gram-Negative Infections
Lama Hsaiky et al.
ANNALS OF PHARMACOTHERAPY (2013)
Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea
B. Kim et al.
INFECTION (2013)
Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients
Fleur Wolff et al.
TALANTA (2013)
Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
Emilia Titelman et al.
APMIS (2011)
In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli
M. Tarnberg et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals
H. Rodriguez-Villalobos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae
Indran Balakrishnan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Effect of Obesity on the Pharmacokinetics of Drugs in Humans
Michael J. Hanley et al.
CLINICAL PHARMACOKINETICS (2010)
Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock
Fabio Silvio Taccone et al.
CRITICAL CARE (2010)
Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli
Jennifer M. Adams-Haduch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A systematic review on clinical benefits of continuous administration of β-lactam antibiotics
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Temocillin revived
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Antibiotic resistance - What's dosing got to do with it?
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2008)
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection
Raf De Jongh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Continuous infusion of beta-lactams
Johan W. Mouton et al.
CURRENT OPINION IN CRITICAL CARE (2007)
Activity of temocillin against prevalent ESBL- and AmpC-producing enterobacteriaceae from south-east england
DM Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update
JW Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid
WA Craig
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units
N Baririan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients
H Servais et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)